Application Detail

Status

Open

Description of Medical Service

ImmunoHistoChemistry test for evaluation of Programmed Cell Death-Ligand 1 (PD-L1) expression to determine eligibility for treatment with pembrolizumab

Description of Medical Condition

Locally advanced/unresectable or metastatic urinary bladder cancer

Reason for Application

New MBS item

Medical Service Type

Investigative

Previous Application Number

Not Applicable

Associated Documentation

Application Form

-

PICO Confirmation

Consultation Protocol (PDF 1132 KB)
Consultation Protocol (Word 706 KB)

Assessment Report

-

Public Summary Document

-

Meetings for this Application

PASC

11 - 12 August 2016

ESC

-

MSAC

-